ACKGROUND: Busulfan, a chemotherapeutic drug, is an alkylating antineoplastic agent that belongs to the class of alkyl sulfonates and has some side effects on fertility. This research was aimed to investigate the effects of busulfan on testicular tissue and serum levels of anti-Mullerian hormone (AMH) and testosterone in adult mice.
Introduction
While infertility has increased up to 50% since 1955, it is now one of the most crucial medical fields of research. Application of chemotherapy and radiotherapy in the treatment of malignant diseases may lead to temporary or permanent infertility. The antimitotic antineoplastic and DNA alkylating agent busulfan (1,4-butanediol dimethanesulphonate) has long been used in the chronic myeloid leukemia treatment and has also used before the stem cells transplantation of many other cancers being used.(1) Busulfan affects slowly proliferating, and nonproliferating cells. (2) Busulfan has also been applied to induce azoospermia in mice, and to study fertility restoration and recovery kinetics of spermatogonial stem cells (SSCs) . (3) It is shown that busulfan in association with other alkylating agents or just alone, can cause SSC death (4), prolonged azoospermia (5), and consequently infertility or subfertility in males (6) . Busulfan induces DNA alkylation in sperm that cause to DNA-DNA and DNA-protein cross-links.(7) While alkylating agents may also affect Sertoli cells (8) , some recent studies reported that busulfan treatment had not caused degeneration of Sertoli cells.
Cytostatic and cytotoxic effects of busulfan exert on cells that are at the G1 phase. The cells would be killed during mitosis, while the ones in S or G2 phase will be killed in next mitosis.(4) Even though, the effects of busulfan on spermatogenesis can be irreversible, there have been just few studies dedicated to busulfan side effects on testis structure, and fertility indices in animal models.(5) Administrating Busulfan would kill several species of SSCs, which results in male infertility. While its administration to pregnant animals, leads to producing germ-cell-free gonads in the offspring. (9) AMH is a 140-kDa homodimeric glycoprotein which is a member of transforming growth factor-β (TGF-β) super family. (10) In both mouse and human, during fetal development, AMH is one of the first genes to be activated in Sertoli cells.(11) Inhibin B is another factor that is regulated by meiotic germ cells, and it regulates folliclestimulatig hormone (FSH) secretion through negative feedback mechanism. AMH with inhibin B and FSH, is an important index of Sertoli cell function. It is reported that after chemotherapy, serum and testicular AMH levels is increased in both mouse and human. This conclusion could be drawn that lack of germ cells, followed by exogenous damage, results in dematuration or dedifferentiation of Sertoli cells. In adult males it is revealed that AMH affect Sertoli cells and leydig cells in autocrine and paracrine manners, respectively. AMH can inhibit differentiation of leydig cells, and spermatogenesis and may also be involved in sperm motility. Although, spermatogenesis is induced by FSH and testosterone, AMH level would be reduced; hence the hormones may have a conflicting effect in AMH regulation.(10) Some study shown that busulfan treatment not affected on leydig cells and serum concentration of LH and FSH not changed.
As it was showed earlier for older male rats, prenatal exposure to busulfan reduces the plasma level of testosterone. After busulfan induction, a significant decrease in total diameter of seminiferous tubules per testis was observed which conforms to previous studies.
The aim of this study was evaluation of the effects of busulfan on testicular tissue and serum levels of AMH and testosterone in adult mice.
Methods

Animals
Eighteen adult male Balb/C mice (10 weeks old and weighing 30±2 g) were adopted in the study. The animals were assigned into two busulfan-treated groups (including azoospermia group and spontaneous recovery group, n=6 in each group), and one control group (n=6). They were provided from Shiraz Medical Sciences Research Center and Experimental Animal House and were let to adapt to the new place condition for one week. Mice were maintained in the institute's animal house in standard hard bottom polypropylene cages at 23ºC±2ºC, 12:12 hours light/ dark cycle and had free access to laboratory chow and tap water throughout the study. The animal experiments were performed with conform to the animal protection guidelines approved by the Ethics Committee for Experimental Animal Use at Shiraz Branch, Islamic Azad University, Shiraz, Iran (Ethical code: IR.Miau 13952009).
Experimental Protocol
The azoospermia and spontaneous recovery groups were intraperitoneally injected with 10 mg/kg -1 body weight of busulfan (Busilvex, Pierre Fabre Medicament, Boulogne, France) in two doses with 21-days interval. The control group received no injection of busulfan. The busulfan dose was determined based on those of previous studies using rat and hamster, in which disrupted spermatogenesis and induced azoospermia were reported using this dose. (12) The duration of spermatogenesis in mouse is approximately 35 days, with four cycles of 8.6 days.(13) At day 35 (approximately 4 cycles) and 140 (approximately 16 cycles) after the last injection, the animals of azoospermia and spontaneous recovery groups were anesthetized with ether, respectively and the blood samples were taken and then were euthanized for testis removal. The same process was done for the control group too.
Histologic and Histomorphometric Analysis
After blood sample collection, the mice testes were removed and were fixed in 10% formalin solution (SigmaAldrich, St. Louis, MO, USA) and were embedded in paraffin. Five sections of five-micron thickness were prepared, and stained with hematoxylin and eosin, and were observed under a light microscope (Nikon, Tokyo, Japan). Accord to Panahi, et al., 10 round and roughly round seminiferous tubules within a section, were measured using Dinocapture 2.0 software (Dino-Eye, San-Chung, Statistical analyses of data were done using SPSS v.24 (SPSS Inc., Chicago, IL). For data normalization, Kolmogorov-Smirnov test was performed; then, ANOVA and Tukey post-hoc test were done to determine whether there were differences among all groups. Mann-Whitney U test was done to compare the spermatogenesis index of seminiferous tubules between groups. Comparisons were made between control and treated groups within the same period. Data are presented as means ± SEM (GraphPad Prism 5.01, Inc., San Diego, CA, USA). Differences were considered to be statistically significant at the 95% confidence level (p˂0.05).
Results
Taiwan) with 100x magnification.(12) Then, nine histomorphometric parameters were measured randomly, which include total, lumen and cellular diameters of seminiferous tubules, luminal, cellular and cross sectional areas of seminiferous tubules, numerical density and number of profiles per unit area and its spermatogenesis index.
The total diameter (D) was calculated based on mean value of two diameters (D 1 and D 2 ) at right angles:
In the same manner, the lumen diameter (L) was achieved based on mean value of two diameters (L 1 
AMH and Testosterone Assay
The blood samples were directly collected from the heart and then centrifuged at 400 g for 20 minutes and stored at -80°C until the day of the analysis. AMH and testosterone were measured by enzyme-linked immunosorbent assay (ELISA) (BT Lab, China) and radioimmunoassay (RIA) (Isotopes Ltd, Hungary) kits, respectively.
Statistical Analysis
Histologic and Histomorphometric Findings
Histological characteristics of seminiferous tubules were compared between control and busulfan-treated groups using light microscope (Figure 1) . Meanwhile, the comparison of mean and standard error of histomorphometric indices of seminiferous tubules in the control, azoospermia and spontaneous recovery groups in mice have been shown in Figure 2 .
Based on the histomorphometric findings, full spermatogenic activity was detected in control and spontaneous recovery groups. In azoospermia group, decreased thickness of germinal epithelium, range and vacuolar space on the basement membrane of the seminiferous tubules were observed. Sertoli cells were visible and spermatogenesis was completely destroyed. In addition, according to histomorphometric findings the total, lumen and cellular diameters, luminal, cellular and cross-sectional areas and spermatogenesis index in the seminiferous tubules of azoospermia group were less than control and spontaneous recovery groups (p˂0.05). But, the number of tubules and numerical density in the seminiferous tubules of azoospermia group were more than control and spontaneous recovery groups (p˂0.05). the total, lumen and cellular diameters, luminal, cellular and cross sectional areas, number of tubules and numerical density and spermatogenesis index in the seminiferous tubules of spontaneous recovery group had no significant difference compared to the control group (p˃0.05). Figure 3 indicates comparison of mean and standard error of AMH and testosterone levels in busulfan treatment and 
AMH and Testosterone Levels
Discussion
Busulfan known as a strong agent that preferentially kills several species SSCs and when it intoxicates the cells in G1 phase, inhibits the next mitosis. (14) However busulfan has no effects on DNA synthesis, but it has side effects on various organs, including the bladder, liver, skin, gonadal function and, nervous system and is potentially mutagenic and carcinogenic. (15) In despite of the tremendous usefulness in biotechnology and chronic diseases therapy, its exact effects on the testis structure and epididymal-spermatozoa parameters have not been well studied. (16) Recent studies demonstrated that chemotherapy drugs such as busulfan can cause testicular damage as manifested by oligospermia, reduced testicular volume and apoptotic cell death on testicular germinal epithelium. Variation of mice testicular histopathology and spermatogenesis potency in response to two injections of busulfan were investigated in present study. Our results demonstrated that there were no significant differences in AMH and testosterone serum levels. Disrupt spermatogenesis was observed in induced azoospermia and restoration of spermatogenesis spontaneously had already been done.
Moisan, et al., showed when 20 mg/kg of busulfan doses administrated in mice, testicular masses went from a maximum to a minimum value. Histological evaluation suggested that the higher testis weights and diameters could be attributed to higher spermatogenesis levels from controls and 10 mg/kg dose group. Eight weeks after busulfan treatment, the increase in testis weight was most clear in treated animals at a 10 mg/kg dose suggesting extensive regeneration of spermatogenesis at mentioned dose. Probably busulfan had no effect on capsular thickness, because at high dose which testis more affected by drug, control groups. Results analyses showed no significant differences in AMH and testosterone serum levels (p˃0.05). Present study assigns detailed information on the busulfan effects on testicular tissue and serum levels of AMH and testosterone in adult mice. Used dosage of Busulfan prescription has no effect on AMH and testosterone serum levels but it is caused to destruction of the germinal epithelium and major reduction of histomorphometric indices of seminiferous tubules. In the other hand busulfan dosage injection can cause temporary azoospermia which is a good way to provide animal models in cell therapy research. Also, presented study indicates that spermatogenesis can occur spontaneously after busulfan therapy. So it can be used as a biomarker in spermatogenesis disorders and fertility in cancer patients.
Conclusion
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